The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

The ALS Association is urging members of Congress to take action to address issues with instability in leadership at the NIH.

Even after 15 years with her husband's ALS, losing caregivers still brings about grief and stress for columnist Kristin Neva.

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

For columnist Dagmar Munn, using the momentum of "swingtime" is helping her manage ALS-related stress and get through tasks.

Shionogi plans to acquire global rights to Radicava and Radicava ORS for ALS through a new U.S. business formed by Tanabe ...

ALS patients and their caregivers benefit most from flexible psychological support that combines emotional care, open ...

Ed and his wife Karen were shocked to hear his ALS diagnosis, but with the help of the VA and others in their community, they discovered they were far from alone. This content is sponsored by Tanabe ...